1. Characteristics and Outcomes of Hospice Enrollees with Dementia Discharged Alive
- Author
-
James A. Tulsky, Maragatha Kuchibhatla, Katja Elbert-Avila, and Kimberly S. Johnson
- Subjects
Male ,Gerontology ,medicine.medical_specialty ,Activities of daily living ,Palliative care ,Referral ,Psychological intervention ,Statistics, Nonparametric ,Article ,Quality of life ,Risk Factors ,Outcome Assessment, Health Care ,Humans ,Medicine ,Dementia ,Registries ,Aged ,Aged, 80 and over ,Chi-Square Distribution ,business.industry ,Hospices ,Length of Stay ,medicine.disease ,Patient Discharge ,United States ,Cross-Sectional Studies ,Logistic Models ,Emergency medicine ,Medicare Hospice ,Female ,Geriatrics and Gerontology ,business ,End-of-life care - Abstract
Dyspnea, pain, agitation, and burdensome interventions are common in the last months of life in individuals with dementia.1–3 Hospice is associated with improvements in end-of-life care for these individuals, including better symptom management, fewer hospitalizations, and greater caregiver satisfaction.4–10 Although hospice enrollment in individuals with dementia is increasing, these individuals are still referred to hospice at lower rates than those with some other life-limiting illnesses.11–14 For example, in a study of Medicare beneficiaries, 41% of those who died of dementia used hospice, compared with 65% of those who died of cancer, which is the single most common admission diagnosis of hospice enrollees.11,14 Hospice providers commonly cite difficulty with prognostication due to variability in disease progression as a barrier to hospice referral for individuals with dementia.15–17 National Hospice and Palliative Care Organization (NHPCO) Guidelines for determining prognosis in dementia are based on the Functional Assessment Staging (FAST), a seven-step staging system that identifies progressive cognitive and functional decline. These guidelines suggest that an appropriate cutoff for enrolling persons with dementia in hospice is stage 7C (completely dependent in all activities of daily living, nonambulatory, limited or no speech) along with the presence of one or more dementia-related comorbidities (e.g., aspiration pneumonia, urinary tract infection, impaired nutritional status).18,19 A number of studies suggest that these criteria do not accurately predict 6-month mortality, which is a requirement for certification under the Medicare Hospice Benefit.19–23 These criteria also do not include other factors associated with poorer survival in individuals with dementia, including older age, male sex, and comorbidities such as diabetes mellitus and heart disease.19,23,24 In the absence of accurate tools for prognostication, not surprisingly, individuals with dementia enrolled in hospice have longer lengths of stay than individuals with cancer, who tend to have a more-predictable trajectory of decline in the last months of life.25–27 In 2005, the median length of stay for Medicare beneficiaries with dementia who enrolled in hospice was 27 versus 20 days for those with cancer, and one-quarter of those with dementia had lengths of stay exceeding 180 days, compared with fewer than 10% of individuals with cancer.28 In addition to longer lengths of stay, hospice enrollees with dementia are also more likely than those with cancer to be discharged from hospice alive because their condition stabilizes or improves and they no longer meet eligibility criteria.29,30 In 2008, Medicare beneficiaries with dementia or other neurological conditions who were discharged alive made up 18% to 41% of all hospice discharges, whereas those with cancer who were discharged alive made up only 10% to 24% of hospice discharges.13 Although longer lengths of stay, female sex, better functional status, and having a noncancer diagnosis have been associated with being discharged alive from hospice,30 little is known about which individuals with dementia are likely to be discharged because they stabilize and no longer meet prognostic eligibility criteria or about what happens to them after they are discharged. This information would be valuable in the current regulatory environment with greater scrutiny of hospice providers to identify fraud and misuse of the Medicare Hospice Benefit related to enrollment of individuals who have prognoses exceeding 6 months.13,31,32 Given the longer lengths of stay of enrollees with dementia than for those with other diagnoses, utilization review and fraud investigators may tend to focus on the charts of these individuals and on hospice providers whose enrollees include a significant proportion diagnosed with dementia. Because of concerns about allegations of fraud and difficulties with accurate prognostication, hospice providers may be cautious about admitting or retaining individuals with dementia.31,32 Using data from a large national hospice provider, the purpose of this study was to compare the characteristics of individuals with dementia who died while receiving hospice with the characteristics of those who were discharged alive because their condition stabilized or improved and to identify factors associated with death in the year after discharge from hospice in individuals who were discharged alive. Understanding which individuals with dementia are likely to be discharged alive from hospice and, of those, which are likely to die in the year after discharge may improve prognostication in hospice enrollees with dementia and inform the development of other services that may contribute to quality of life for those who are no longer eligible for hospice care.
- Published
- 2012
- Full Text
- View/download PDF